Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

NOVARTIS INDIA LTD. - 500672 - Compliance Certificate For The Financial Year Ended On March 31, 2022, In Terms Of The Provisions Of Regulations 40(9) & (10) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Please note that in terms of the SEBI (LODR) Regulations, 2015, the Company has obtained a Compliance Certificate from Saraf & Associates, Company Secretaries, for the financial year ended on March 31, 2022 and the same is being submitted herewith. This is for your information and record.
21-04-2022
Bigul

NOVARTIS INDIA LTD. - 500672 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In reference to the above captioned subject, the certificate dated April 8, 2022, issued by the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited, in terms of the provisions of the said Regulations, for the quarter and year ended March 31, 2022, is enclosed herewith for your records. This is for your information and record.
21-04-2022
Bigul

NOVARTIS INDIA LTD. - 500672 - Statement Of Investor Complaints For The Quarter Ended March 2022

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Sanjay MurdeshwarDesignation :- Managing Director / Whole Time Director
12-04-2022
Bigul

NOVARTIS INDIA LTD. - 500672 - Board to consider Final Dividend

 Novartis India Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on May 19, 2022, to inter alia consider the Audited financial results of the Company for the fourth quarter and financial year ending on March 31, 2022 ("said results") and recommendation of final dividend on Equity Share, if any, for the said year.In this connection, further note that pursuant to the Company''s Code of Conduct to regulate, monitor and report share trading by Insiders ["the Code"], the trading window for dealing in securities of the Company shall remain closed from April 01, 2022 to May 21, 2022 (both days inclusive).
31-03-2022
Bigul

NOVARTIS INDIA LTD. - 500672 - Board Meeting Intimation for Considering The Audited Financial Results Of The Company For The Fourth Quarter And Financial Year Ending On March 31, 2022

 NOVARTIS INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2022 ,inter alia, to consider and approve the Audited financial results of the Company for the fourth quarter and financial year ending on March 31, 2022 ("said results") and recommendation of final dividend on Equity Share, if any, for the said year.
31-03-2022
Bigul

NOVARTIS INDIA LTD. - 500672 - Closure of Trading Window

 Dear Sir/ Madam, Please be informed that the meeting of the Board of Directors of the Company is scheduled to be held on Thursday, May 19, 2022, to inter alia consider the Audited financial results of the Company for the fourth quarter and financial year ending on March 31, 2022 ("said results") and recommendation of final dividend on Equity Share, if any, for the said year. In this connection, further note that pursuant to the Company''s Code of Conduct to regulate, monitor and report share trading by Insiders ["the Code"], the trading window for dealing in securities of the Company shall remain closed from Friday, April 1, 2022 to Saturday, May 21, 2022 (both days inclusive).
31-03-2022
Bigul

NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that we are issuing a duplicate share certificate to the shareholder as detailed in the attachment, as per the information received from the Company's Registrar and Share Transfer Agent on March 15, 2022. Request you to take the same on record as required under the provisions of the said Regulation.
17-03-2022
Bigul

NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Dear Sirs, Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that as per the information received from the Company's Registrar and Share Transfer Agent on February 23, 2022, a shareholder has reported the loss of share certificate as detailed in the attachment. Request you to take the same on record as required under the provisions of the said Regulation.
25-02-2022
Bigul

NOVARTIS INDIA LTD. - 500672 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Dear Sirs, Please find enclosed herewith the copies of the newspaper Notices in 'Financial Express' and 'Navshakti' on February 12, 2022. This is for your information and record.
15-02-2022
Bigul

NOVARTIS INDIA LTD. - 500672 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Dear Sirs, Please find enclosed herewith the following: 1. Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 2. Media Report Kindly take the same on record.
11-02-2022
Next Page
Close

Let's Open Free Demat Account